Snap Diagnostics Funding: How Much Did They Raise & Key Investors

How Much Did Snap Diagnostics Raise?
Funding & Key Investors

Snap Diagnostics, a medical device and service company focused on obstructive sleep apnea solutions, has secured significant enterprise-level funding, with its total funding reaching $2.5M. The company recently announced a major strategic investment of $1.5M, underscoring its continued growth and market presence in the diagnostic and management sector for sleep disorders.

What is Snap Diagnostics?

Snap Diagnostics

Manufacturing

Medical Devices & Equipment

Healthcare Services

Founded in 1994 and headquartered in Wheeling, Illinois, SNAP Diagnostics is a private entity dedicated to the development, manufacturing, and marketing of products aimed at aiding in the diagnosis, analysis, and management of obstructive sleep apnea. The company's focus on this critical health issue positions it within the growing medical technology market, addressing a significant unmet need in patient care and health management.

How much funding has Snap Diagnostics raised?

Snap Diagnostics has raised a total of $2.5M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$1.5M

Debt (2020): $1M with participation from PPP

Debt (2021): $1.5M led by PPP

Key Investors in Snap Diagnostics

PPP

Public-Private Partnership

PPP

Public-Private Partnership

What's next for Snap Diagnostics?

The recent major strategic investment signals a pivotal phase for Snap Diagnostics, likely enabling accelerated product development, market expansion, and enhanced service offerings. This infusion of capital, part of its $2.5M in total financing, suggests a strategic push to solidify its position in the sleep apnea diagnostics market and potentially explore new technological advancements or therapeutic solutions. The company's trajectory indicates a strong commitment to innovation and patient well-being in the sleep health sector.

See full Snap Diagnostics company page

See More Financial Insights